Join to View Full Profile
1825 4th StreetFouth floorSan Francisco, CA 94158
Phone+1 415-353-9888
Fax+1 415-353-9805
Dr. Al Rabadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2017 - 2020
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 2012 - 2015
Royal College of Surgeons IrelandClass of 2012
Certifications & Licensure
CA State Medical License 2014 - 2026
OR State Medical License 2015 - 2023
OH State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsAdo-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab.Luai Al Rabadi, Madeline Cook, Andy Kaempf, Megan M. Saraceni, Michael A. Savin
BMC Cancer. 2021-04-06 - 39 citationsEverolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy.Madeline Cook, Luai Al Rabadi, Andy Kaempf, Megan M. Saraceni, Michael A. Savin
The Oncologist. 2021-02-01 - 9 citationsPhase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy.Julie N. Graff, Mark N. Stein, Rishi Surana, Luai Al Rabadi, E Liu
Frontiers in Oncology. 2020-08-07
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
